grid-line

Semaglutide

1.22M
Volume
+4900%
Growth
exploding

Turn Trends into Views🚀

Type in a topic to instantly see search volume, difficulty and related topics. All for free.

Free insights powered by
About the Topic

Medication used for the treatment of type 2 diabetes and long-term weight management. It belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, which mimic the GLP-1 hormone to regulate blood sugar levels and appetite. This medication is primarily targeted at individuals with type 2 diabetes or those seeking medical assistance for weight management.

Semaglutide was discovered on May 23rd 2023 and it currently has a search volume of 1.22M with a growth of +4900%.

Key Indicators
Growth
  • Exploding
  • Regular
  • Peaked
Speed
  • Exponential
  • Constant
  • Stationary
Seasonality
  • High
  • Medium
  • Low
Volatility
  • High
  • Average
  • Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Related Topics

Save this topic and build your own trend dashboard.

Available with Exploding Topics Pro, try it now.